S
Stephen Attwood
Researcher at Durham University
Publications - 143
Citations - 11575
Stephen Attwood is an academic researcher from Durham University. The author has contributed to research in topics: Eosinophilic esophagitis & Esophagus. The author has an hindex of 45, co-authored 132 publications receiving 10022 citations. Previous affiliations of Stephen Attwood include Newcastle University & Creighton University.
Papers
More filters
Journal ArticleDOI
W1092 Exocrine and Endocrine Gastric Mucosal Changes Under Medical or Surgical Antireflux Therapy. Results of a 5-Yr Follow up in the Lotus Trial
Roberto Fiocca,Luca Mastracci,Stephen Attwood,Christian Ell,Jean-Paul Galmiche,Jan Gunnar Hatlebakk,Anna Reveman,Göran Långström,Tore Lind,Lars Lundell +9 more
Journal Article
Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation. Author's reply
Abstract: Patients with Barrett's oesophagus have a risk of approximately 1 per 100 patient‐years for the development of oesophageal adenocarcinoma. Endoscopic ablation of Barrett's oesophagus has been shown to lead to the regrowth of a ‘neo’ squamous epithelium if gastro‐oesophageal reflux is controlled, but the incidence of subsequent tumour formation is unknown.
Journal ArticleDOI
309 - Prolongation of Eosinophilic Esophagitis Treatment with Budesonide Orodispersible Tablets for Incomplete Responder is Effective and Safe: Results from a 6-Weeks Open-Label Treatment Phase of the Pivotal Trial EOS-1
Alfredo J. Lucendo,Stephan Miehlke,Michael Vieth,Christoph Schlag,Ulrike von Arnim,Javier Molina-Infante,Dirk Hartmann,Albert J. Bredenoord,Constanza Ciriza de los Ríos,Stefan Schubert,Stefan Brückner,Ahmed Madisch,Jamal O. Hayat,Jan Tack,Stephen Attwood,Ralph Mueller,Roland Greinwald,Alain M. Schoepfer,Alex Straumann +18 more
Book ChapterDOI
Argon Plasma Coagulation in Barrett’s Esophagus: The Most Widely Available Technique
TL;DR: A series of 32 patients with high-grade dysplasia were treated with APC and Dysplasia reversed in 78% of patients and cancer prevented in 87% with 34 months of follow-up.
Journal ArticleDOI
eQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma.
Xiaoyu Wang,Puya Gharahkhani,David K. Levine,Rebecca C. Fitzgerald,Ines Gockel,Douglas A. Corley,Harvey A. Risch,Leslie Bernstein,Wong Ho Chow,Lynn Onstad,Nicholas J. Shaheen,Jesper Lagergren,Laura J. Hardie,Anna H. Wu,Paul D.P. Pharoah,Geoff Liu,Lesley A. Anderson,Prasad G. Iyer,Marilie D. Gammon,Carlos Caldas,Weimin Ye,Hugh Barr,Paul Moayyedi,Rebecca Harrison,Rg Peter Watson,Stephen Attwood,Laura Chegwidden,Sharon Love,David MacDonald,J Decaestecker,Hans Prenen,Katja Ott,Susanne Moebus,Marino Venerito,Hauke Lang,Rupert Mayershofer,Michael Kappl,Lothar Veits,Christian Gerges,J. Weissmüller,Matthias Reeh,Markus M. Nöthen,Jakob R. Izbicki,Hendrik Manner,Horst Neuhaus,Thomas Rösch,Anne C. Böhmer,Arnulf H. Hölscher,Mario Anders,Oliver Pech,Brigitte Schumacher,Claudia Schmidt,Thomas Schmidt,Tania Noder,Dietmar Lorenz,Michael Vieth,Andrea May,Timo Hess,Nicole Kreuser,Jessica Becker,Christian Ell,Ian Tomlinson,Claire Palles,Janusz Jankowski,David C. Whiteman,Stuart MacGregor,Johannes Schumacher,Thomas L. Vaughan,Matthew F. Buas,James Y. Dai +69 more
TL;DR: This study expanded the pool of genetic susceptibility loci for EAC and BE, suggesting the potential of the eQTL set based genetic association approach as an alternative method for TWAS analysis.